Patents by Inventor Carlos ZARAGOZA

Carlos ZARAGOZA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220233572
    Abstract: The present disclosure related to methods to treat, prevent (e.g., suppress, inhibit or delay), or ameliorate the symptoms of a TLR-4 mediated disease or condition comprising administering an aptamer of the present disclosure to a subject in need thereof, alone or combination with other pharmacological and/or surgical interventions. In a particular aspect, the aptamers of the present disclosure are administered before, during, or after pharmacological and/or surgical interventions (e.g., thrombolysis such as thrombectomy) or any combination thereof, for the treatment of ischemic (e.g., myocardial infarction or ischemic stroke), hemorrhagic (e.g., hemorrhagic stroke or hemorrhagic transformation), or neurodegenerative (e.g., multiple sclerosis) diseases or conditions. The disclosure also provides specific doses and dosage regimes.
    Type: Application
    Filed: May 16, 2020
    Publication date: July 28, 2022
    Applicant: APTATARGETS, S.L.
    Inventors: Macarena HERNÁNDEZ JIMÉNEZ, Carlos ZARAGOZA, David PIÑEIRO DEL RIO, Fernando DE CASTRO SOUBRIET, Beatriz FERNANDEZ GÓMEZ, Ignacio LIZASOAIN HERNÁNDEZ, Maria Ángeles MORO SÁNCHEZ, Lisardo BOSCÁ GOMAR, Diego PÉREZ RODRÍGUEZ, David SEGARRA DE LA PEÑA, María Eugenia ZARABOZO LEAL
  • Patent number: 9693509
    Abstract: Biodegradable mulch of the type used in various agricultural applications is made by multi-layer extrusion from a mixture of two compostable biodegradable polymers that comply with the EN13432 standard and that include potato starch, a black masterbatch and biodegradable recycled polymers. The mulch self-degrades in a short period of time, becoming a compostable material that enriches the soil, avoiding the collecting and cleaning tasks that are necessary in conventional mulches.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: July 4, 2017
    Assignee: SPHERE GROUP SPAIN, S.L.
    Inventors: Alfonso Biel Borraz, Carlos Zaragoza Larios, Alicia Cirujeda Ranzenberger, Joaquin Aibar Lete, Ana Isabel Marí León, Inmaculada Lahoz García, Juan Ignacio Macua Gonzalez, Maria Luisa Suso Martínez de Bujo, Nuria Vázquez García, Marta María Moreno Valencia, Carmen Moreno Valencia, Ramón Meco Murillo, Lluis Martín Closas, Ana María Pelacho Aja, Joan Costa Tura
  • Patent number: 9644019
    Abstract: The present invention relates to the use of an Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) inhibitor for preventing and/or treating cardiac damage arising after an ischemic process followed by reperfusion. The authors of the present invention have observed that EMMPRIN expression increases in subjects who have suffered ischemia/reperfusion, ascertaining that an EMMPRIN inhibitor is capable of reducing the cardiac damage caused after ischemia followed by reperfusion, both in vitro and in vivo.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: May 9, 2017
    Inventors: Carlos Zaragoza Sánchez, Mónica Gómez Parrizas, Begoña Lavín Plaza, Carlos Tarín Cerezo
  • Publication number: 20160000022
    Abstract: Biodegradable mulch of the type used in various agricultural applications is made by multi-layer extrusion from a mixture of two compostable biodegradable polymers that comply with the EN13432 standard and that include potato starch, a black masterbatch and biodegradable recycled polymers. The mulch self-degrades in a short period of time, becoming a compostable material that enriches the soil, avoiding the collecting and cleaning tasks that are necessary in conventional mulches.
    Type: Application
    Filed: February 14, 2014
    Publication date: January 7, 2016
    Applicant: SPHERE GROUP SPAIN, S.L.
    Inventors: Alfonso BIEL BORRAZ, Carlos ZARAGOZA LARIOS, Alicia CIRUJEDA RANZENBERGER, Joaquin AIBAR LETE, Ana Isabel MARÍ LEÓN, Inmaculada LAHOZ GARCÍA, Juan Ignacio MACUA GONZALEZ, Maria Luisa SUSO MARTÍNEZ DE BUJO, Nuria VÁZQUEZ GARCÍA, Marta María MORENO VALENCIA, Carmen MORENO VALENCIA, Ramón MECO MURILLO, Lluis MARTÍN CLOSAS, Ana María PELACHO AJA, Joan COSTA TURA
  • Publication number: 20140148396
    Abstract: The present invention relates to the use of an EMMPRIN inhibitor for preventing and/or treating cardiac damage arising after an ischemic process followed by reperfusion. The authors of the present invention have observed that EMMPRIN expression increases in subjects who have suffered ischemia/reperfusion, ascertaining that an EMMPRIN inhibitor is capable of reducing the cardiac damage caused after ischemia followed by reperfusion, both in vitro and in vivo.
    Type: Application
    Filed: December 1, 2011
    Publication date: May 29, 2014
    Inventors: Carlos Zaragoza Sánchez, Mónica Gómez Parrizas, Begona Lavín Plaza, Carlos Tarin Cerezo